Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of two iPSC intestinal differentiation protocols

ABSTRACT: RNA-seq of two iPSC intestinal differentiation protocols

PROVIDER: PRJEB72505 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR12651881_1.fastq.gz	Fastqsanger.gz
	ERR12651881_2.fastq.gz	Fastqsanger.gz
	ERR12651882_1.fastq.gz	Fastqsanger.gz
	ERR12651882_2.fastq.gz	Fastqsanger.gz
	ERR12651883_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

RNA-seq of two iPSC intestinal differentiation protocols

Project description:Same iPSC line was differentiated according to two protocols for comparison (n=6). Protocol 1 (AC) is a novel protocol while Protocol 2 (AW) is a comparator protocol. At the end of both protocols, cell lysates were collected, RNA extracted and analysed by bulk mRNA-sequencing targeting 50 million paired-end 150bp reads per sample.

2026-03-03 | E-MTAB-13785 | biostudies-arrayexpress

scRNA-seq of iPSC-derived dendritic cells under distinct differentiation and maturation protocols

Project description:Dendritic cells (DCs) derived from human induced pluripotent stem cells (iPSCs) offer a promising platform for immunotherapy and disease modeling. To optimize differentiation protocols for generating functionally distinct DC subsets, we performed single-cell RNA sequencing (scRNA-seq) on iPSC-derived DCs cultured under various combinations of cytokine-driven differentiation and maturation conditions. We compared the effects of GM-CSF, IL-4, FLT3L, and different maturation cocktails including TNF-α, IL-1β, PGE2, and IFN-γ (mat2) or IFN-β (mat3). The dataset captures transcriptional profiles of cells representing both monocyte-like and migratory dendritic cell populations. These data provide a valuable resource for understanding iPSC-DC heterogeneity and guiding the development of engineered DC-based therapies.

2026-08-25 | GSE297820 | GEO

Transcriptional signatures in iPSC-derived neurons are reproducible across labs when differentiation protocols are closely matched

Project description:Reproducibility of expression patterns in iPSC-derived cells from different labs is an important first step in ensuring replication of biochemical or functional assays that are performed in different labs. Here we show that reproducible gene expression patterns from iPSCs and iPSC-derived neurons matured and collected at two separate laboratory locations can be achieved by closely matching protocols and reagents. While there are significant differences in gene expression between iPSCs and differentiated neurons, as well as between different donor lines of the same cell type, transcriptional changes that vary with laboratory sites are relatively small. These results suggest that making great efforts to match protocols, reagents and technical methods between labs may improve the reproducibility of iPSC-derived cell models.

2021-12-01 | GSE167051 | GEO

scRNA-seq of iPSC-derived dendritic cells under distinct differentiation and maturation protocols

Project description:scRNA-seq of iPSC-derived dendritic cells under distinct differentiation and maturation protocols

| PRJNA1266228 | ENA

Comparison of human pluripotent stem cell differentiation protocols to generate neuroblastoma tumors.

Project description:Neuroblastoma is the most common extra cranial solid tumor derived from sympathoadrenal (SA) cells and characterized as either adrenergic or mesenchymal. Here, we compared four different protocols to differentiate induced pluripotent stem cells (iPSC) toward SA cells and intermediate cell states (neuromesodermal progenitors [NMP], trunk neural crest cells [tNCC]) as well as generating MYCN-driven tumors. Interestingly, the protocols that created cells with the highest level of NMP markers did not produce cells with the highest tNCC or SA cell markers. We identified a protocol that consistently produced cells with the highest level of SA markers using two iPSC lines of different genders. This protocol also generated tumors with the highest level of the neuroblastoma-specific marker, PHOX2B. Transcriptomally, however, each protocol generates tumors that resemble neuroblastoma. Two of the protocols repeatedly produced adrenergic neuroblastoma whereas the other two protocols were ambiguous. Thus, we identified a protocol that reliably generates adrenergic neuroblastoma.

2024-09-09 | GSE264211 | GEO

Human iPSC-EC differentiation

Project description:Human iPSC-EC differentiation

| PRJNA479006 | ENA

Transcriptional signatures in iPSC-derived neurons are reproducible across labs when differentiation protocols are closely matched

Project description:Transcriptional signatures in iPSC-derived neurons are reproducible across labs when differentiation protocols are closely matched

| PRJNA702793 | ENA

EZH2 inhibitor GSK126 promotes human iPSC hematopoietic differentiation

Project description:The de novo generation of human hematopoietic stem cells (HSCs) from induced pluripotent stem cells (iPSCs) represents a promising avenue for the cellular therapy of blood disorders. However, existing protocols often result in the production of immature progenitors with limited multilineage engraftment capacity in vivo. This limitation is believed to be due to an epigenetic barrier, particularly involving the Polycomb Repressor Complex 2 (PRC2), which mediates transcriptional repression during hematopoietic development through H3K27me3 methylation. In this study, we explored the suppression of EZH2, a key component of PRC2, using the small molecule inhibitor GSK126 at various stages of iPSC differentiation. Our findings revealed that EZH2 inhibition leads to an increase in phenotypic HSCs and enhances long-term colony-forming unit (CFU) colony formation. Single-cell RNA sequencing further demonstrated that GSK126 promotes iPSC hematopoietic differentiation. These results highlight the potential of EZH2 inhibition to overcome epigenetic barriers and enhance iPSC-derived hematopoietic differentiation, paving the way for advancements in regenerative medicine and transplantation therapies.

2026-08-10 | GSE342748 | GEO

Integrative multi-omics analysis of intestinal organoid differentiation

Project description:Intestinal organoids accurately recapitulate epithelial homeostasis in vivo, thereby representing a powerful in vitro system to investigate lineage specification and cellular differentiation. Here, we applied a multi-omics framework on stem cell enriched and -depleted mouse intestinal organoids to obtain a holistic view of the molecular mechanisms that drive differential gene expression during adult intestinal stem cell differentiation. Our data revealed a global rewiring of the transcriptome and proteome between intestinal stem cells and enterocytes, with the majority of dynamic protein expression being transcription-driven. Integrating absolute mRNA and protein copy numbers revealed post-transcriptional regulation of gene expression. Probing the epigenetic landscape identified a large number of cell-type specific regulatory elements, which revealed Hnf4g as a major driver of enterocyte differentiation. In summary, by applying an integrative systems biology approach we uncovered multiple layers of gene expression regulation, which contribute to lineage specification and plasticity of the mouse small intestinal epithelium.

2018-06-25 | PXD009700 | Pride

Single cell RNA sequencing of in vitro differentiation NMP protocols

Project description:Single cell RNA sequencing of in vitro differentiation NMP protocols

| PRJNA548192 | ENA